Jill Beyer

机构：Massachusetts Eye and Ear Infirmary

发表论文 72 篇 · 总被引 3638 次 · h-index 33

代表论文

• In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir (2017 · Antimicrobial Agents and Chemotherapy · 被引 139)
• In Vitro and In Vivo Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A (2014 · Antimicrobial Agents and Chemotherapy · 被引 131)
• In Vitro Activity and Resistance Profile of Dasabuvir, a Nonnucleoside Hepatitis C Virus Polymerase Inhibitor (2014 · Antimicrobial Agents and Chemotherapy · 被引 123)
• Resistance Analysis of Baseline and Treatment-Emergent Variants in Hepatitis C Virus Genotype 1 in the AVIATOR Study with Paritaprevir-Ritonavir, Ombitasvir, and Dasabuvir (2015 · Antimicrobial Agents and Chemotherapy · 被引 95)
• In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir (2017 · Antimicrobial Agents and Chemotherapy · 被引 91)
• O057 : Long-term follow-up of treatment-emergent resistance-associated variants in NS3, NS5A and NS5B with paritaprevir/r-, ombitasvir- and dasabuvir-based regimens (2015 · Journal of Hepatology · 被引 84)